| First Author | Xu F | Year | 2016 |
| Journal | Nat Commun | Volume | 7 |
| Pages | 13527 | PubMed ID | 27869115 |
| Mgi Jnum | J:242858 | Mgi Id | MGI:5906963 |
| Doi | 10.1038/ncomms13527 | Citation | Xu F, et al. (2016) Cerebral vascular amyloid seeds drive amyloid beta-protein fibril assembly with a distinct anti-parallel structure. Nat Commun 7:13527 |
| abstractText | Cerebrovascular accumulation of amyloid beta-protein (Abeta), a condition known as cerebral amyloid angiopathy (CAA), is a common pathological feature of patients with Alzheimer's disease. Familial Abeta mutations, such as Dutch-E22Q and Iowa-D23N, can cause severe cerebrovascular accumulation of amyloid that serves as a potent driver of vascular cognitive impairment and dementia. The distinctive features of vascular amyloid that underlie its unique pathological properties remain unknown. Here, we use transgenic mouse models producing CAA mutants (Tg-SwDI) or overproducing human wild-type Abeta (Tg2576) to demonstrate that CAA-mutant vascular amyloid influences wild-type Abeta deposition in brain. We also show isolated microvascular amyloid seeds from Tg-SwDI mice drive assembly of human wild-type Abeta into distinct anti-parallel beta-sheet fibrils. These findings indicate that cerebrovascular amyloid can serve as an effective scaffold to promote rapid assembly and strong deposition of Abeta into a unique structure that likely contributes to its distinctive pathology. |
